Noveris Health Sciences Inc. is trading at $1.90, down 20.8% today after announcing a leadership transition within its advisory board.

  • The company issued a news release on June 12, 2026, naming Nathan Mison as the new Chair of its Advisory Board.
  • The stock is currently retreating following a period of sharp volatility and a prior technical rebound, with the leadership update serving as the primary company-specific catalyst.